Trexquant Investment LP Neogenomics Inc Transaction History
Trexquant Investment LP
- $7.59 Billion
- Q3 2024
A detailed history of Trexquant Investment LP transactions in Neogenomics Inc stock. As of the latest transaction made, Trexquant Investment LP holds 203,669 shares of NEO stock, worth $3.09 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
203,669
Previous 42,545
378.71%
Holding current value
$3.09 Million
Previous $590,000
409.15%
% of portfolio
0.04%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding NEO
# of Institutions
294Shares Held
124MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$299 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$213 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$105 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$100 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$99.3 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.91B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...